These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 9204233)

  • 21. Antenatal maternal serum profiles.
    Spencer K
    Br J Hosp Med; 1994 Mar 2-15; 51(5):243-6. PubMed ID: 7518729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in antenatal screening for Down syndrome.
    Wald NJ; Hackshaw AK
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):563-80. PubMed ID: 10985931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study.
    Jørgensen FS; Valentin L; Salvesen KA; Jørgensen C; Jensen FR; Bang J; Eik-Nes SH; Madsen M; Marsal K; Persson PH; Philip J; Bogstad JW; Nørgaard-Pedersen B
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):501-10. PubMed ID: 10376859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
    Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 27. Prenatal diagnosis of structural abnormalities.
    Sanders RC
    Curr Opin Obstet Gynecol; 1991 Apr; 3(2):259-65. PubMed ID: 1717021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-Fetoprotein screening.
    Burton BK
    Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [How women cope with the results of maternal serum screening for fetal neural tube defects and Down syndrome].
    Kamerbeek LI; Roelofsen EE; Beekhuis JR; Tijmstra T; Mantingh A
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1308-11. PubMed ID: 7688449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antenatal screening for neural tube defects and Down's syndrome--the importance of pretest counselling.
    Seman E
    Med J Aust; 1994 May; 160(10):658-60. PubMed ID: 8177121
    [No Abstract]   [Full Text] [Related]  

  • 31. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV; Rozenberg P; Bernard JP; Ville Y
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
    [No Abstract]   [Full Text] [Related]  

  • 32. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
    Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
    Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal biochemical diagnostics of inborn developmental defects.
    Malbohan I; Fialová L; Mikulíková L; Hájek Z
    Sb Lek; 1994; 95(4):277-83. PubMed ID: 8867698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-trimester screening for neural tube defects using alpha-fetoprotein.
    Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
    Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.
    Brajenović-Milić B; Tislarić D; Bacić J; Paravić J; Slivar AE; Kapovic M; Kosec V; Ristic S; Rajhvajn B
    Fetal Diagn Ther; 1998; 13(6):367-71. PubMed ID: 9933821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of incorrect gestational dating on Down's syndrome and neural tube risk assessment.
    Millner SN
    Ann Clin Biochem; 2001 May; 38(Pt 3):230-4. PubMed ID: 11392497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A; Akkawi M
    East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases].
    Arbuzova SB; Nikolenko MI
    Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.